{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:21:50Z","timestamp":1788999710121,"version":"build-2803163510"},"reference-count":29,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"National Institutes of Health (NIH) National Heart"},{"name":"Lung and Blood Institute","award":["PO1-HL55782"],"award-info":[{"award-number":["PO1-HL55782"]}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","doi-asserted-by":"crossref","award":["R01-DK081352"],"award-info":[{"award-number":["R01-DK081352"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","doi-asserted-by":"crossref","award":["R01-DK088778"],"award-info":[{"award-number":["R01-DK088778"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1016\/j.atherosclerosis.2012.08.006","type":"journal-article","created":{"date-parts":[[2012,8,20]],"date-time":"2012-08-20T21:45:17Z","timestamp":1345499117000},"page":"526-531","source":"Crossref","is-referenced-by-count":45,"title":["The levels of MDA-LDL in circulating immune complexes predict myocardial infarction in the VADT study"],"prefix":"10.1016","volume":"224","author":[{"given":"Maria F.","family":"Lopes-Virella","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly J.","family":"Hunt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathaniel L.","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Virella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Moritz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2012.08.006_bib1","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJM199901143400207","article-title":"Atherosclerosis \u2013 an inflammatory disease","volume":"340","author":"Ross","year":"1999","journal-title":"N\u00a0Eng J Med"},{"key":"10.1016\/j.atherosclerosis.2012.08.006_bib2","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1002\/(SICI)1096-9896(199906)188:2<174::AID-PATH333>3.0.CO;2-3","article-title":"Cytokin secretion profiles of cloned T cells from human aortic atherosclerotic plaques","volume":"188","author":"De Boer","year":"1999","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.atherosclerosis.2012.08.006_bib3","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0021-9150(88)90074-3","article-title":"Localization of T lymphocytes and macrophages in fibrous and complicated human atherosclerotic plaques","volume":"72","author":"Hansson","year":"1988","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2012.08.006_bib4","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.clim.2009.07.016","article-title":"Innate immune signals in atherosclerosis","volume":"134","author":"Lundberg","year":"2010","journal-title":"Clin Immunol"},{"key":"10.1016\/j.atherosclerosis.2012.08.006_bib5","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMra043430","article-title":"Inflammation, atherosclerosis, and coronary artery disease","volume":"352","author":"Hansson","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2012.08.006_bib6","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.atherosclerosis.2008.03.025","article-title":"Atherogenesis and the humoral immune response to modified lipoproteins","volume":"200","author":"Virella","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2012.08.006_bib7","doi-asserted-by":"crossref","first-page":"582","DOI":"10.2337\/db10-0915","article-title":"The levels of oxidized LDL and AGE-LDL in circulating immune complexes are strongly associated with increased levels of carotid intima-media thickness and its progression in type 1 diabetes","volume":"60","author":"Lopes-Virella","year":"2011","journal-title":"Diabetes"},{"key":"10.1016\/j.atherosclerosis.2012.08.006_bib8","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1194\/jlr.M400095-JLR200","article-title":"Definition of the immunogenic forms of modified human LDL recognized by human autoantibodies and by rabbit hyperimmune antibodies","volume":"45","author":"Virella","year":"2004","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.atherosclerosis.2012.08.006_bib9","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1194\/jlr.M600064-JLR200","article-title":"OxLDL immune complexes activate complement and induce cytokine production by MonoMac 6 cells and human macrophages","volume":"47","author":"Saad","year":"2006","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.atherosclerosis.2012.08.006_bib10","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.atherosclerosis.2008.05.032","article-title":"Oxidized LDL immune complexes and oxidized LDL differentially affect the expression of genes involved with inflammation and survival in human U937 monocytic cells","volume":"202","author":"Hammad","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2012.08.006_bib11","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1161\/01.ATV.15.7.990","article-title":"Immune complexes of LDL induce atherogenic responses in human monocytic cells","volume":"15","author":"Kiener","year":"1995","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2012.08.006_bib12","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1172\/JCI114271","article-title":"Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man","volume":"84","author":"Yla-Herttuala","year":"1989","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.atherosclerosis.2012.08.006_bib13","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1093\/eurheartj\/11.suppl_E.88","article-title":"Lipoproteins in normal and atherosclerotic aorta","volume":"11","author":"Yla-Herttuala","year":"1990","journal-title":"Eur Heart J"},{"key":"10.1016\/j.atherosclerosis.2012.08.006_bib14","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.atherosclerosis.2006.02.007","article-title":"Immune complexes containing modified lipoproteins are related to the progression of internal carotid intima-media thickness in patients with type 1 diabetes","volume":"190","author":"Lopes-Virella","year":"2007","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2012.08.006_bib15","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.atherosclerosis.2010.11.012","article-title":"Oxidized LDL immune complexes and coronary artery calcification in type 1 diabetes","volume":"214","author":"Lopes-Virella","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2012.08.006_bib16","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1161\/01.ATV.16.2.222","article-title":"Isolation and characterization of human antioxidized LDL autoantibodies","volume":"16","author":"Mironova","year":"1996","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2012.08.006_bib17","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/S1056-8727(02)00277-5","article-title":"Design of the cooperative study on glycemic control and complications in diabetes mellitus type 2: Veterans Affairs Diabetes Trial","volume":"17","author":"Abraira","year":"2003","journal-title":"J\u00a0Diabetes Complicat"},{"key":"10.1016\/j.atherosclerosis.2012.08.006_bib18","first-page":"S32","article-title":"Standards of medical care for patients with diabetes mellitus","volume":"23","author":"ADA","year":"2000","journal-title":"Diabetes Care"},{"key":"10.1016\/j.atherosclerosis.2012.08.006_bib19","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.clim.2008.02.005","article-title":"Distribution of IgM and IgG antibodies to oxidized LDL in immune complexes isolated from patients with type 1 diabetes and its relationship with nephropathy","volume":"127","author":"Virella","year":"2008","journal-title":"Clin Immunol"},{"key":"10.1016\/j.atherosclerosis.2012.08.006_bib20","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1128\/CDLI.12.1.68-75.2005","article-title":"Development of capture assays for different modifications of human low-density lipoprotein","volume":"12","author":"Virella","year":"2005","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.atherosclerosis.2012.08.006_bib21","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1172\/JCI117963","article-title":"Malondialdehyde-modified low density lipoproteins in patients with atherosclerotic disease","volume":"95","author":"Holvoet","year":"1995","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.atherosclerosis.2012.08.006_bib22","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1161\/01.CIR.98.15.1487","article-title":"Oxidized LDL and malondialdehyde-modified LDL in patients with acute coronary syndromes and stable coronary artery disease","volume":"98","author":"Holvoet","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2012.08.006_bib23","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0021-9150(97)00157-3","article-title":"The uptake of LDL-IC by human macrophages: predominant involvement of the Fc gamma RI receptor","volume":"135","author":"Lopes-Virella","year":"1997","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2012.08.006_bib24","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1161\/01.ATV.0000201041.14438.8d","article-title":"OxLDL-IgG immune complexes induce survival of human monocytes","volume":"26","author":"Oksjoki","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2012.08.006_bib25","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.atherosclerosis.2006.08.002","article-title":"The relationship between oxidized LDL and other cardiovascular risk factors and subclinical CVD in different ethnic groups: the Multi-Ethnic Study of Atherosclerosis (MESA)","volume":"194","author":"Holvoet","year":"2007","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2012.08.006_bib26","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1161\/01.ATV.0000021150.63480.CD","article-title":"Circulating oxidized LDL is associated with subclinical atherosclerosis development and inflammatory cytokines (AIR Study)","volume":"22","author":"Hulthe","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2012.08.006_bib27","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.atherosclerosis.2003.05.001","article-title":"Increased circulating malondialdehyde-modified LDL in the patients with familial combined hyperlipidemia and its relation with the hepatic lipase activity","volume":"172","author":"Yamazaki","year":"2004","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2012.08.006_bib28","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1128\/CDLI.10.4.499-505.2003","article-title":"Lipoprotein autoantibodies: measurement and significance","volume":"10","author":"Virella","year":"2003","journal-title":"Clin Diag Lab Immunol"},{"key":"10.1016\/j.atherosclerosis.2012.08.006_bib29","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1161\/01.ATV.0000251503.35795.4f","article-title":"Biomarkers of atherosclerotic plaque instability and rupture","volume":"27","author":"Koenig","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915012005539?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915012005539?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,12]],"date-time":"2020-07-12T14:56:23Z","timestamp":1594565783000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915012005539"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["S0021915012005539"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2012.08.006","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]}}}